-
Chairman Cummings Opening Statement for the Examination of Companies' Actions in Raising Drug Prices
-
U.S. Drug Prices: $1,000 drugs
A small number of pricy brand-name drugs are responsible for the lion’s share of prescription spending. -
Why Don't We Invest More in Public Health?
Many, many studies conclude that investing in public health is more effective than continually increasing spending on expensive treatments. So why doesn't the US spend more on public health? -
Can Public Policy Control Rising Drug Prices?
Exploring whether drug prices will continue to rise at extraordinary rates.
Comments